CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Grant or award Chief Marketing Officer acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 8-K Event Results of operations
- 4 Grant or award Director acquired 36,508 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 2,597,475 shares at $9.50 ($24,676,013)
- 4 Open-market buy 10% owner bought 51,000 shares at $10.93 ($557,568)
- 4 Open-market buy 10% owner bought 110,000 shares at an average $11.06 ($1,216,791)
- 4 Open-market sale Director sold 26,077 shares at $11.00 ($286,722)
Page 15 of 28 · 558 filings